Perspectives: The Ca2+-dependent K+-channel K Ca3.1 as a therapeutic target in cardiovascular disease

European Heart Journal, Supplement

Volumn 16, Issue SUPPL.A, 2014, Pages

  Windler, Rainer ^a,b   De Wit, Cor ^a,b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

EDHF; Endothelium; Hyperpolarization; Hypertension; Microcirculation

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM ACTIVATED POTASSIUM CHANNEL KCA3.1; G PROTEIN COUPLED RECEPTOR; NITRIC OXIDE; UNCLASSIFIED DRUG;

ARTERIAL PRESSURE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM; ENDOTHELIUM CELL; HUMAN; HYPERPOLARIZATION; NEOINTIMA; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 84892758049     PISSN: 1520765X     EISSN: 15542815     Source Type: Journal    
DOI: 10.1093/eurheartj/sut008     Document Type: Article

References (17)

1. de Wit C, Griffith TM. Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses. Pflugers Arch 2010;459: 897-914.
2. de Wit C, Boettcher M, Schmidt VJ. Signaling across myoendothelial gap junctions-fact or fiction?. Cell Commun Adhes 2008;15: 231-245.
3. Köhler R, Kaistha BP, Wulff H. Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease. Expert Opin Ther Targets 2010;14:143-155.
4. Köhler R, Ruth P. Endothelial dysfunction and blood pressure alterations in K+-channel transgenic mice. Pflugers Arch 2010;459:969-976.
5. Si H, Heyken WT,Wölfle SE, Tysiac M, Schubert R, Grgic I, Vilianovich L, Giebing G, Maier T, Gross V, Bader M, de Wit C, Hoyer J, Köhler R. Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel. Circ Res 2006; 99:537-544.
6. Brähler S, Kaistha A, Schmidt VJ,Wölfle SE, Busch C, Kaistha BP, Kacik M, Hasenau AL, Grgic I, Si H, Bond CT, Adelman JP, Wulff H, de Wit C, Hoyer J, Köhler R. Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension. Circulation 2009;119:2323-2332.
7. Milkau M, Köhler R, de Wit C. Crucial importance of the endothelial K+ channel SK3 and connexin40 in arteriolar dilations during skeletal muscle contraction. FASEB J 2010;24:3572-3579.
8. Hasenau AL, Nielsen G, Morisseau C, Hammock BD, Wulff H, Köhler R. Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small-and intermediate-conductance Ca2+-activated K+-channels. Acta Physiol (Oxf) 2011;203:117-126.
9. Radtke J, Schmidt K,WulffH, Köhler R, de Wit C. Activation of KCa3. 1 by SKA-31 induces arteriolar dilation and lowers blood pressure in normoand hypertensive connexin40-deficient mice. Br J Pharmacol 2013; 170:293-303.
10. Wölfle SE, Schmidt VJ, Hoyer J, Köhler R, de Wit C. Prominent role of KCa3. 1 in endothelium-derived hyperpolarizing factor-type dilations and conducted responses in the microcirculation in vivo. Cardiovasc Res 2009;82:476-483.
11. Sankaranarayanan A, Raman G, Busch C, Schultz T, Zimin PI, Hoyer J, Köhler R,Wulff H. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), anewactivator of KCa2 and KCa3. 1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol Pharmacol 2009;75:281-295.
12. Damkjaer M, Nielsen G, Bodendiek S, Staehr M, Gramsbergen J, de Wit C, Jensen BL, Simonsen U, Bie P,Wulff H, Köhler R. Pharmacological activation of KCa3. 1/KCa2. 3 channels produces endothelial hyperpolarisation and lowers blood pressure in conscious dogs. Br J Pharmacol 2012;165:223-234.
13. Jobs A, Schmidt K, Schmidt VJ, Lübkemeier I, van Veen TAB, Kurtz A, Willecke K, de Wit C. Defective Cx40 maintains Cx37 expression but intact Cx40 is crucial for conducted dilations irrespective of hypertension. Hypertension 2012;60:1422-1429.
14. Mishra RC, Belke D,Wulff H, Braun AP. SKA-31, a novel activator of SKCa and IKCa channels, increases coronary flow in male and female rat hearts. Cardiovasc Res 2013;97:339-348.
15. Tharp DL, Wamhoff BR, Turk JR, Bowles DK. Upregulation of intermediate-conductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle. Am J Physiol Heart Circ Physiol 2006;291:H2493-H2503.
16. Tharp DL, Bowles DK. The intermediate-conductance Ca2+-activated K+ channel (KCa3. 1) in vascular disease. Cardiovasc Hematol Agents Med Chem 2009;7:1-11.
17. Toyama K, Wulff H, Chandy KG, Azam P, Raman G, Saito T, Fujiwara Y, Mattson DL, Das S, Melvin JE, Pratt PF, Hatoum OA, Gutterman DD, Harder DR, Miura H. The intermediate-conductance calcium-activated potassium channel KCa3. 1 contributes to atherogenesis in mice and humans. J Clin Invest 2008;118:3025-3037.